All outcome measures showed a trend towards poorer quality of life with greater doses of OCS, except for the comparison between those on no prednisolone versus those prescribed 1–9 mg·day −1 .
1
—
—
All outcome measures showed a trend towards poorer quality of life with greater doses of OCS, except for the comparison between those on no prednisolone versus those prescribed 1–9 mg·day −1 .